Yujun_Wong
@Yujun__Wong
Followers
212
Following
544
Statuses
252
Hepatologist | Cirrhosis & Portal hypertension | HCV | 🇨🇦🇸🇬 retweet≠endorsement
Edmonton, Canada
Joined February 2022
🔔Non-🍺 cirrhosis had a higher risk of mortality after AVB. ⭐️Conventional indices overestimate the mortality risk in patients with 🍺 cirrhosis due to poor correlation with serum bilirubin🟡 Here is why 👇
3
4
10
RT @rabataller: I always tell my patients with recompensated cirrhosis following a long period of abstinence: “Congrats for this achieveme…
0
10
0
RT @ebtapper: BREAKING: rifaximin and simvastatin did not help people with decompensated cirrhosis Congratulations to @PoseElisa And con…
0
71
0
RT @NoureddinMD: What a day in the history of MASH! Reversal of Fibrosis in MASH cirrhotics by 24% (paired) and 17% (ITT) all sig P values.…
0
46
0
RT @acv69cardenas: Check out our latest article. Hemodynamic profile of terlipressin and octreotide in patients with cirrhosis and portal h…
0
14
0
RT @DrHuangDQ: ➡️HBV reactivation in immunosuppression can kill ➡️Who needs antivirals to prevent HBV flares? 😳 ➡️A useful quick referenc…
0
38
0
RT @MCarbone_80: Can we predict failure to #OCA in #PBC patients? The simple answer is YES❗️ OCA-response score: a novel tool to drive tr…
0
18
0
RT @TerryYip12: New study at @JHepatology unveils how two-step clinical care pathway for #MASLD predicts #MALOs. Many thanks to all collabo…
0
16
0
@TerryYip12 @JHepatology @VWSWong @wonglaihung @CUHKMedicine @CUHKGI Congratulations, @TerryYip12 ! 🙂👍🏻
1
0
1
RT @JHEP_Reports: 🟪NEW Article in press❕ Minimal residual ascites three months after TIPS implantation indicates worse clinical outcome in…
0
8
0
RT @ruben_hernaez: 🚨 AGA New Guideline Alert Link🚨 ▶️ AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus…
0
52
0
RT @chinghuisia: GLP-1 RAs significantly reduce weight (-4.57 kg), BMI (-2.07 kg/m²), and waist circumference (-4.55 cm) in individuals wit…
0
5
0
RT @Maasoumy_lab: 🆕 Treatment of refractory #ascites: TIPS, tunneled peritoneal catheter, or ascites pump? 🥇 TIPS: lowest incidence of com…
0
24
0
RT @f_tavaglione: Excited🤩 to share our newly published paper in @APandT demonstrating PEth🍺 as an accurate, quantitative, objective alcoho…
0
16
0
RT @CiroCelsa: In press on @AGA_CGH our multicenter study 🇮🇹 🇬🇧 on 293 pts with PBC 🔥 Non-invasive tests for portal hypertension perform p…
0
11
0
RT @drnipunverma: 🌟 Breakthrough in preventing hepatic encephalopathy (HE) recurrence! 🌟 🦠 A Phase 2 RCT of FMT in cirrhosis & HE patients…
0
18
0
RT @APandT: Read open access at "Early Dynamics of Portal Pressure Gradient After TIPS Insertion Predict Mortality"…
0
6
0
RT @Maasoumy_lab: 🆕 Identification of optimal portal pressure decrease to control #ascites while minimizing HE after #TIPS: A multicenter s…
0
11
0
RT @Maasoumy_lab: 🆕 TIPS insertion leads to sustained reversal of systemic inflammation in patients w/ decompensated liver cirrhosis 💡decr…
0
6
0
RT @JasmohanBajaj: In pts w #hepaticencephalopathy on max Rx..how can we⬇️recurrence? #gutbrainaxis In our #FMT Phase 2 trial @JHepatology…
0
16
0